seri
larginin
deriv
design
synthes
assay
activ
aminopeptidas
n
apn
result
show
compound
exhibit
high
inhibitori
activ
apn
low
activ
within
seri
two
compound
ic
lm
show
similar
inhibitori
activ
compar
bestatin
ic
lm
could
use
novel
lead
compound
futur
apn
inhibitor
develop
anticanc
agent
aminopeptidas
n
ec
zincdepend
metalloproteinas
cleav
neutral
basic
amino
acid
nterminu
oligopeptid
scientist
found
outsid
hematopoiet
system
apn
wide
express
variou
kind
cell
exampl
epitheli
cell
intestin
kidney
hepatocyt
osteoclast
endometri
cell
fibroblast
endotheli
cell
bone
marrow
stromal
cell
neuron
synapt
membran
apn
involv
mani
physiolog
patholog
process
hydrolysi
nutrient
inactiv
bioactiv
peptid
bind
corona
virus
mediat
cytomegaloviru
infect
antigen
present
furthermor
apn
target
antitumor
agent
due
import
function
ecm
degrad
tumor
cell
invas
tumor
angiogenesi
past
two
decad
sever
apn
inhibitor
found
exampl
bestatin
probestin
amastatin
actinonin
phebestin
lapstatin
ahpav
leuhistin
curcumin
pasmmaplin
among
bestatin
launch
wide
employ
clinic
antitumor
agent
structur
apn
studi
accord
cocryst
complex
apn
bestatin
kiyoshi
group
studi
bind
site
catalyt
domain
apn
base
cocryst
complex
bind
site
apn
bestatin
divid
three
part
part
hydrophob
pocket
part
zinc
bind
group
zbg
part
anoth
hydrophob
pocket
side
help
computeraid
molecular
design
group
design
synthes
seri
llysin
deriv
found
compound
exhibit
potenti
apn
inhibitori
activ
fig
also
crystal
structur
escherichia
coli
aminopeptidas
n
e
pepn
complex
larginin
llysin
lphenylalanin
ltyrosin
ltryptophan
determin
understand
structur
basi
apn
hydrolysi
pattern
result
show
amino
acid
bind
backbon
atom
close
activesit
zinc
ion
side
chain
occupi
pocket
e
pepn
specif
bind
pocket
suggest
prefer
amino
acid
decreas
order
arginin
lysin
tyrosin
phenylalanin
addit
arginin
similar
lysin
structur
except
guanidinium
group
longer
carbon
chain
accord
former
reason
choos
larginin
start
materi
order
get
effici
potenti
apn
inhibitor
compound
design
show
figur
target
compound
design
synthes
via
rout
shown
scheme
guanidinium
group
see
front
matter
elsevi
ltd
right
reserv
compound
protect
nitro
group
get
compound
compound
esterif
methanol
hcl
atmospher
get
compound
acyl
compound
acyl
chlorid
carboxyl
acid
sulfochlorid
led
compound
b
final
ester
group
b
treat
nhok
anhydr
methanol
get
target
compound
b
inhibit
result
list
tabl
similar
apn
also
zincdepend
metalloproteinas
involv
tumor
invas
metastasi
thu
assay
perform
apn
identifi
compound
select
bestatin
use
posit
control
almost
compound
except
show
better
activ
apn
exampl
ic
ic
apn
ratio
equal
equal
result
certain
extent
confirm
strategi
design
apn
inhibitor
possibl
descript
differ
structur
two
enzym
lead
differ
requir
respect
inhibitor
apn
membranebound
zinc
exopeptidas
catalyz
remov
nh
termin
amino
acid
peptid
zincdepend
endopeptidas
could
cut
peptid
part
specif
amino
acid
residu
peptid
former
llysin
deriv
deriv
design
group
inhibit
apn
show
better
activ
larginin
deriv
suitabl
apn
inhibitor
compar
could
find
compound
contain
substitut
phenyl
group
better
activ
contain
unsubstitut
phenyl
group
among
compound
conclud
compound
contain
two
substitut
group
phenyl
group
potent
activ
other
activ
compound
contain
bisubstitut
phenyl
group
worth
mention
moieti
also
effect
preciou
llysin
deriv
possibl
reason
might
substitut
benzen
ring
could
accommod
hydrophob
site
apn
suitabl
suggest
potenti
moieti
apn
inhibitor
compound
b
could
confirm
compound
contain
sulfonyl
group
show
equal
activ
apn
coincid
fact
sulfonyl
group
contain
compound
group
synthes
show
better
inhibitori
activ
activ
compound
ic
lm
compar
activ
bestatin
ic
lm
also
consider
activ
ic
lm
respect
order
investig
interact
compound
apn
activ
compound
construct
sybyl
sketch
modul
optim
use
powel
method
tripo
forc
field
converg
criterion
set
kcal
mol
assign
method
perform
use
sybylflexx
modul
residu
radiu
around
bestatin
cocryst
structur
pdb
code
select
activ
site
dock
paramet
impli
program
kept
default
figur
see
backbon
insert
pocket
hydroxym
interact
zinc
ion
apn
benzamid
side
chain
extend
pocket
detail
understand
bind
mode
apn
pictur
also
creat
program
ligplot
figur
see
backbon
could
form
hydrophob
contact
glu
met
tyr
pocket
form
hydrogen
bond
glu
imin
guanidinium
group
two
oxygen
atom
hydroxym
chelat
zinc
ion
apn
carbonyl
amid
r
posit
could
form
hydrogen
bond
gli
ala
pocket
r
substitut
side
chain
could
form
hydrophob
contact
gli
pocket
nitro
group
aromat
ring
could
form
hydrogen
bond
arg
arg
although
comput
inform
partial
support
assumpt
exact
bind
mode
larginin
deriv
apn
obtain
xray
crystal
studi
synthes
new
seri
laginin
deriv
apn
inhibitor
compound
show
potent
activ
select
apn
compar
bestatin
could
use
lead
compound
develop
ment
futur
low
molecularweight
peptidomimet
apn
inhibitor
anticanc
agent
materi
commerci
avail
solvent
except
fume
nitric
acid
fume
sulfur
acid
distil
use
reaction
monitor
thinlay
chromatographi
mm
silica
gel
plate
visual
uv
light
chlorid
ferric
mesh
silica
gel
use
column
chromatographi
proton
nmr
spectra
determin
brucker
drx
spectromet
mhz
part
per
million
j
hertz
tm
use
intern
standard
measur
made
solut
esim
determin
api
spectromet
element
analysi
compound
perform
use
elementar
vario
el
iii
cn
analyz
germani
melt
point
determin
electrotherm
melt
point
apparatu
uncorrect
titl
compound
prepar
describ
hashimoto
et
al
compound
titl
compound
prepar
describ
jordi
compound
phenylacet
acid
g
mmol
trimethylamin
equiv
dissolv
ml
anhydr
dichloromethan
dcm
stir
solut
ad
tbtu
equiv
follow
compound
result
solut
stir
h
wash
satur
na
co
citric
acid
brine
lie
white
solid
precipit
dcm
filter
wash
dcm
dri
vacuum
dri
oven
final
g
product
obtain
yield
compound
synthes
follow
procedur
describ
compound
g
mmol
triethylamin
equiv
mix
ml
anhydr
dcm
icebath
chlorid
equiv
dissolv
dcm
ad
dropwis
result
solut
stir
h
wash
satur
na
co
citric
acid
brine
lie
white
solid
would
precipit
dcm
solid
filter
wash
dcm
dri
vacuum
dri
oven
final
g
product
obtain
yield
compound
synthes
follow
procedur
describ
compound
synthes
follow
procedur
compound
final
g
product
got
yield
compound
synthes
follow
procedur
compound
methyl
phenylsulfonamido
pentano
g
solut
compound
g
mmol
ml
anhydr
methanol
room
temperatur
ad
dropwis
solut
nhok
mmol
methanol
ml
mixtur
stir
h
solvent
evapor
vacuum
residu
purifi
column
chromatographi
dichloromethan
methanol
final
g
obtain
white
solid
yield
compound
b
synthes
follow
procedur
describ
